Carlo Vancheri
About
Carlo Vancheri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology.
According to data from OpenAlex, Carlo Vancheri has authored 261 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Pulmonary and Respiratory Medicine, 111 papers in Physiology and 26 papers in Epidemiology. Recurrent topics in Carlo Vancheri's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (140 papers), Asthma and respiratory diseases (47 papers) and Sarcoidosis and Beryllium Toxicity Research (45 papers). Carlo Vancheri is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (140 papers), Asthma and respiratory diseases (47 papers) and Sarcoidosis and Beryllium Toxicity Research (45 papers). Carlo Vancheri collaborates with scholars based in Italy, United Kingdom and Germany. Carlo Vancheri's co-authors include Nunzio Crimi, Elisa Gili, Maria Angela Sortino, Evelina Fagone, Mary Fruciano, Enrico Conte, Claudio Mastruzzo, Maria Iemmolo, Sebastiano Emanuele Torrisi and Riccardo Polosa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.
In The Last Decade
Carlo Vancheri
245 papers receiving 7.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carlo Vancheri Italy | 48 | 4.5k | 2.6k | 1.4k | 653 | 639 | 261 | 7.6k | ||
| Hisamichi Aizawa Japan | 42 | 3.1k 0.7× | 2.8k 1.1× | 1.2k 0.9× | 873 1.3× | 571 0.9× | 240 | 6.3k | ||
| Hiroyuki Taniguchi Japan | 48 | 6.5k 1.5× | 2.3k 0.9× | 1.4k 1.0× | 352 0.5× | 1.0k 1.6× | 242 | 8.9k | ||
| Benjamin A. Raby United States | 50 | 2.5k 0.5× | 3.0k 1.2× | 1.9k 1.4× | 1.6k 2.5× | 554 0.9× | 194 | 7.4k | ||
| Takashi Izumi Japan | 41 | 1.8k 0.4× | 1.5k 0.6× | 1.6k 1.2× | 975 1.5× | 591 0.9× | 267 | 7.1k | ||
| Vincent Lagente France | 44 | 2.3k 0.5× | 1.9k 0.7× | 2.3k 1.7× | 1.5k 2.3× | 584 0.9× | 187 | 7.1k | ||
| Noboru Hattori Japan | 40 | 2.8k 0.6× | 827 0.3× | 1.1k 0.8× | 591 0.9× | 609 1.0× | 295 | 5.6k | ||
| Takahide Nagase Japan | 41 | 2.4k 0.5× | 1.8k 0.7× | 2.8k 2.1× | 1.2k 1.8× | 652 1.0× | 288 | 7.7k | ||
| Yoshikazu Kawakami Japan | 45 | 2.6k 0.6× | 1.6k 0.6× | 1.3k 1.0× | 809 1.2× | 459 0.7× | 311 | 6.3k | ||
| Marek Sanak Poland | 44 | 1.5k 0.3× | 2.1k 0.8× | 1.1k 0.8× | 910 1.4× | 330 0.5× | 270 | 5.9k | ||
| Gary P. Anderson Australia | 52 | 3.1k 0.7× | 3.3k 1.3× | 1.9k 1.4× | 2.9k 4.4× | 957 1.5× | 184 | 8.9k |
Countries citing papers authored by Carlo Vancheri
Since
Specialization
Citations
This map shows the geographic impact of Carlo Vancheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Vancheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Vancheri more than expected).
Fields of papers citing papers by Carlo Vancheri
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Carlo Vancheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Vancheri. The network helps show where Carlo Vancheri may publish in the future.
Co-authorship network of co-authors of Carlo Vancheri
This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Vancheri. A scholar is included among the top collaborators of Carlo Vancheri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Vancheri. Carlo Vancheri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Krauss, Ekaterina, Silke Tello, Jennifer Naumann, et al.. (2025). European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD). PLoS ONE. 20(1). e0316484–e0316484.
2.
Sambataro, Domenico, Stefano Palmucci, Francesco Pallotti, et al.. (2025). Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review. Medicina. 61(4). 599–599.
3.
Nolasco, Santi, Evelina Fagone, Raffaele Campisi, et al.. (2025). Effect of the Arg16Gly β 2 ‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study. Allergy. 81(3). 734–749.
4.
Mancuso, Salvatore, et al.. (2024). Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term. Journal of Telemedicine and Telecare. 31(7). 1024–1033.
5.
Manfredi, Andreina, Gianluca Sambataro, Stefania Cerri, et al.. (2024). Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome. Journal of Personalized Medicine. 14(7). 708–708.
6.
Colaci, Michele, Lucia Spicuzza, Domenico Sambataro, et al.. (2024). The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 13(2). 369–369.
7.
Spicuzza, Lucia, Stefano Palmucci, Evelina Fagone, et al.. (2023). Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study. Diagnostics. 13(11). 1882–1882.
8.
Calabria, Silvia, Carlo Piccinni, Antonella Pedrini, et al.. (2023). EPH200 Healthcare Resource Consumption of Patients with Chronic Obstructive Pulmonary Disease Treated with Triple and Dual Therapy and Experiencing an Acute Exacerbation. Value in Health. 26(12). S239–S239.
9.
Crimi, Claudia, Santi Nolasco, Raffaele Campisi, et al.. (2022). Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study. Journal of Clinical Medicine. 11(24). 7323–7323.
10.
Kalluri, Meena, Fabrizio Luppi, Ada Vancheri, et al.. (2021). Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?. European Respiratory Review. 30(160). 210026–210026.
11.
Τzouvelekis, Αrgyris, Κατερίνα Αντωνίου, Michael Kreuter, et al.. (2020). The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus. ERJ Open Research. 7(1). 529–2020.
12.
Distefano, Giulio, Salvatore L. Cosentino, Ada Vancheri, et al.. (2020). HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review. Diagnostics. 10(4). 244–244.
13.
Torrisi, Sebastiano Emanuele, Nicolas Kahn, Julia Wälscher, et al.. (2019). Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. BMC Pulmonary Medicine. 19(1). 213–213.
14.
Vancheri, Carlo, Alfredo Sebastiani, Alberto Pesci, et al.. (2019). Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis. Respiratory Medicine. 156. 78–84.
15.
Sergioli, Giuseppe, G. Russo, Alessandro Stefano, et al.. (2018). Quantum-inspired minimum distance classification in a biomedical context. UNICA IRIS Institutional Research Information System (University of Cagliari).
16.
Vancheri, Carlo, Michael Kreuter, Luca Richeldi, et al.. (2017). Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial. American Journal of Respiratory and Critical Care Medicine. 197(3). 356–363.
17.
Crimi, Nunzio, Claudio Mastruzzo, & Carlo Vancheri. (2005). Bradykinin and Tachykinin-induced Leukotriene Release in Airway Virus Infections. American Journal of Respiratory and Critical Care Medicine. 172(4). 511–511.
18.
Genovese, Tiziana, Salvatore Cuzzocrea, Rosanna Di Paola, et al.. (2005). Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2on bleomycin-induced lung injury. European Respiratory Journal. 25(2). 225–234.
19.
Vancheri, Carlo, Takayuki Ohtoshi, Gerard Cox, et al.. (1991). Neutrophilic Differentiation Induced by Human Upper Airway Fibroblast-derived Granulocyte/Macrophage Colony-stimulating Factor (GM-CSF). American Journal of Respiratory Cell and Molecular Biology. 4(1). 11–17.
20.
Cox, Gerard, Takayuki Ohtoshi, Carlo Vancheri, et al.. (1991). Promotion of Eosinophil Survival by Human Bronchial Epithelial Cells and its Modulation by Steroids. American Journal of Respiratory Cell and Molecular Biology. 4(6). 525–531.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hisamichi Aizawa Breakdown of academic impact, for papers by Hiroyuki Taniguchi Breakdown of academic impact, for papers by Benjamin A. Raby Breakdown of academic impact, for papers by Takashi Izumi Breakdown of academic impact, for papers by Vincent Lagente Breakdown of academic impact, for papers by Noboru Hattori Breakdown of academic impact, for papers by Takahide Nagase Breakdown of academic impact, for papers by Yoshikazu Kawakami Breakdown of academic impact, for papers by Marek Sanak Breakdown of academic impact, for papers by Gary P. Anderson